A detailed history of Great West Life Assurance CO transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 74,554 shares of FOLD stock, worth $782,071. This represents 0.0% of its overall portfolio holdings.

Number of Shares
74,554
Previous 85,104 12.4%
Holding current value
$782,071
Previous $843,000 5.34%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$9.55 - $12.09 $100,752 - $127,549
-10,550 Reduced 12.4%
74,554 $798,000
Q2 2024

Aug 12, 2024

SELL
$9.04 - $11.75 $139,523 - $181,349
-15,434 Reduced 15.35%
85,104 $843,000
Q1 2024

May 13, 2024

BUY
$11.43 - $14.24 $83,484 - $104,008
7,304 Added 7.83%
100,538 $1.18 Million
Q4 2023

Feb 13, 2024

BUY
$9.97 - $14.52 $51,066 - $74,371
5,122 Added 5.81%
93,234 $1.32 Million
Q3 2023

Nov 14, 2023

SELL
$11.78 - $13.86 $6,537 - $7,692
-555 Reduced 0.63%
88,112 $1.07 Million
Q2 2023

Aug 10, 2023

BUY
$10.72 - $13.3 $72,349 - $89,761
6,749 Added 8.24%
88,667 $1.12 Million
Q1 2023

May 12, 2023

SELL
$10.91 - $13.54 $45,145 - $56,028
-4,138 Reduced 4.81%
81,918 $910,000
Q4 2022

Feb 10, 2023

BUY
$9.89 - $12.7 $483,462 - $620,826
48,884 Added 131.51%
86,056 $1.06 Million
Q3 2022

Nov 01, 2022

BUY
$9.82 - $12.75 $365,029 - $473,943
37,172 New
37,172 $387,000
Q2 2022

Aug 09, 2022

BUY
$6.23 - $11.12 $4,043 - $7,216
649 Added 5.14%
13,285 $143,000
Q1 2022

May 12, 2022

BUY
$7.89 - $12.48 $4,868 - $7,700
617 Added 5.13%
12,636 $127,000
Q4 2021

Feb 14, 2022

BUY
$9.82 - $12.44 $5,774 - $7,314
588 Added 5.14%
12,019 $139,000
Q2 2021

Aug 11, 2021

SELL
$8.71 - $10.72 $21,853 - $26,896
-2,509 Reduced 18.0%
11,431 $110,000
Q1 2021

May 17, 2021

SELL
$9.2 - $23.86 $38,143 - $98,923
-4,146 Reduced 22.92%
13,940 $137,000
Q3 2020

Nov 17, 2020

SELL
$12.89 - $15.89 $79,337 - $97,802
-6,155 Reduced 25.39%
18,086 $255,000
Q3 2020

Nov 13, 2020

BUY
$12.89 - $15.89 $79,337 - $97,802
6,155 Added 34.03%
24,241 $342,000
Q4 2019

Feb 11, 2020

BUY
$7.48 - $10.75 $33,286 - $47,837
4,450 Added 32.63%
18,086 $176,000
Q3 2019

Oct 25, 2019

SELL
$8.02 - $13.25 $96,753 - $159,848
-12,064 Reduced 46.94%
13,636 $109,000
Q2 2019

Jul 31, 2019

BUY
$10.96 - $14.4 $975 - $1,281
89 Added 0.35%
25,700 $0
Q1 2019

May 08, 2019

BUY
$10.04 - $13.92 $51,374 - $71,228
5,117 Added 24.97%
25,611 $347,000
Q2 2018

Aug 10, 2018

BUY
$13.13 - $17.09 $67,593 - $87,979
5,148 Added 33.55%
20,494 $320,000
Q1 2018

May 10, 2018

SELL
$13.76 - $17.12 $95,425 - $118,727
-6,935 Reduced 31.13%
15,346 $231,000
Q4 2017

Feb 09, 2018

BUY
$12.51 - $16.24 $98,028 - $127,256
7,836 Added 54.25%
22,281 $320,000
Q3 2017

Nov 09, 2017

BUY
$11.74 - $15.78 $169,584 - $227,942
14,445
14,445 $212,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.94B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.